Regenerative Medical Technology RMTG
OTC RMTG
$0.06 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Regenerative Medical Technology (RMTG) Selling, General & Administrative (2018 - 2026)

Updated

Regenerative Medical Technology (RMTG) recorded Selling, General & Administrative of $619,164 in Q2 2026, up 198.5% from $207,449 a year earlier and up 30.1% from the prior quarter.

Analysis

Regenerative Medical Technology (RMTG) Selling, General & Administrative (2018 - 2026) Analysis & Trends

On a TTM basis, Regenerative Medical Technology's Selling, General & Administrative came in at $1.76 million as of Jun 30, 2026, up 112.2% year-over-year; for FY2025, it was $1.12 million, up 40.3% from FY2024.

  • Annual Selling, General & Administrative has increased for five straight years, with a five-year compound annual growth rate of 106.4% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $798,316 in FY2024 (+6.1%), $752,527 in FY2023 (+77.4%), $424,258 in FY2022 (+184.0%) and $149,374 in FY2021 (+400.1%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q1 2018.
  • On a year-over-year basis, Selling, General & Administrative has increased for four consecutive quarters, with growth averaging 76.6% over the last eight quarters.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 859.9% in Q1 2022, against a decline of 42.0% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $475,812 (Q1 2026), $389,318 (Q4 2025) and $277,696 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Regenerative Medical Technology 824,338.06 -3.70 Mn 2.58 Mn 619,164.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 619,164.00
Mar 31, 2026 475,812.00
Dec 31, 2025 389,318.00
Sep 30, 2025 277,696.00
Jun 30, 2025 207,449.00
Mar 31, 2025 245,566.00
Dec 31, 2024 113,111.00
Sep 30, 2024 264,078.00
Jun 30, 2024 262,037.00
Mar 31, 2024 159,091.00
Dec 31, 2023 195,000.00
Sep 30, 2023 147,084.00
Jun 30, 2023 231,817.00
Mar 31, 2023 178,626.00
Dec 31, 2022 84,726.00
Sep 30, 2022 107,638.00
Jun 30, 2022 130,047.00
Mar 31, 2022 101,847.00
Dec 31, 2021 80,168.00
Sep 30, 2021 52,651.00
API Access

Regenerative Medical Technology Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=RMTG&period=max&api_key=YOUR_API_KEY